1. Home
  2. ASMB vs MRLN Comparison

ASMB vs MRLN Comparison

Compare ASMB & MRLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$26.75

Market Cap

442.9M

Sector

Health Care

ML Signal

HOLD

Logo Merlin Inc. Common Stock

MRLN

Merlin Inc. Common Stock

N/A

Current Price

$3.87

Market Cap

415.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ASMB
MRLN
Founded
2005
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
442.9M
415.1M
IPO Year
2010
2024

Fundamental Metrics

Financial Performance
Metric
ASMB
MRLN
Price
$26.75
$3.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$44.20
$25.00
AVG Volume (30 Days)
245.6K
2.2M
Earning Date
05-06-2026
10-28-2021
Dividend Yield
N/A
N/A
EPS Growth
91.78
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$638.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.90
$4.12
52 Week High
$39.71
$17.00

Technical Indicators

Market Signals
Indicator
ASMB
MRLN
Relative Strength Index (RSI) 50.41 29.73
Support Level $26.18 N/A
Resistance Level $30.68 $6.30
Average True Range (ATR) 1.46 0.52
MACD 0.01 -0.04
Stochastic Oscillator 46.08 2.41

Price Performance

Historical Comparison
ASMB
MRLN

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About MRLN Merlin Inc. Common Stock

Merlin Inc is focused on developing autonomous flight software for legacy and next-generation airborne systems. Its aircraft-agnostic, AI-based software supports takeoff-to-landing autonomous operations for military and civil aviation programs. The company aims to build an AI-based operating software platform intended to support autonomous flight operations across a range of aircraft types.

Share on Social Networks: